Effective July 20, 2022, Adlon Therapeutics has discontinued the sale of Adhansia XR® (methylphenidate HCI) extended-release capsules. Please note, this was a business decision and was not based on any safety or effectiveness concerns. We encourage discussing alternative treatment options with your patients or healthcare provider. If you have any questions, please contact Adlon Medical Information by calling 888-827-0618 and selecting option 1.